Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Should You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?
10:26am, Friday, 02'nd Aug 2024
While Gilead (GILD) has been under pressure year to date due to pipeline setbacks, holding on to this biotech giant should be prudent at current levels.
Gilead Sciences (GILD) Advances While Market Declines: Some Information for Investors
06:51pm, Thursday, 01'st Aug 2024
Gilead Sciences (GILD) closed the most recent trading day at $76.49, moving +0.57% from the previous trading session.
Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 01'st Aug 2024
Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Top 3 Biotech Stocks to Buy Now Summer 2024
04:30pm, Wednesday, 31'st Jul 2024
In the bustling world of biotechnology, innovation remains the cornerstone of growth. Some biotech stocks, known for their groundbreaking research and rapid adaptation to health challenges, are partic
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
10:02am, Wednesday, 31'st Jul 2024
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Monday, 29'th Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
09:04am, Monday, 29'th Jul 2024
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks.
A Look At Gilead Sciences After Its Recent Weakness
03:18am, Saturday, 27'th Jul 2024
Gilead Sciences has dropped 15% YTD, impacted by disappointing trial results from Trodelvy after acquiring Immunomedics for over $20 billion. Despite challenges, the company had a financially strong 1
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
06:15am, Thursday, 25'th Jul 2024
Pfizer is busy growing income streams to replace its big COVID-related revenue from years past. Paycom is profitably helping companies help themselves with self-service software.
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
07:06pm, Monday, 22'nd Jul 2024
Gilead Sciences (GILD) reachead $72.41 at the closing of the latest trading day, reflecting a -0.21% change compared to its last close.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Monday, 22'nd Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
AHF Press Conference: Advocates Demand Gilead to Put Lives Before Profits at AIDS 2024
02:00am, Monday, 22'nd Jul 2024
MUNICH--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) will host an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesd
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
01:58pm, Friday, 19'th Jul 2024
When I think of biotech stocks, I imagine volatile share prices and plenty of red ink. I also think of big-time shareholder returns for the industry's winners.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 18'th Jul 2024
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays
07:15am, Wednesday, 17'th Jul 2024
Dividend stocks can deliver both reliable income and substantial capital appreciation over long periods of time. Investing $51,000 across these three dividend-paying options could yield about $3,000 i
